LIVER-DIRECTED GENE DELIVERY

被引：21
|
作者：
WU, GY
WU, CH
机构：
[1] Department of Medicine, Division of Gastroenterology-Hepatology, University of Connecticut School of Medicine, Farmington, CT
来源：
ADVANCED DRUG DELIVERY REVIEWS | 1993年 / 12卷 / 03期
基金：
美国国家卫生研究院;
关键词：
GENES; TARGETING; ASIALOGLYCOPROTEINS; RECEPTORS;
D O I：
10.1016/0169-409X(93)90057-B
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Cell surface receptors can provide a convenient natural mechanism for delivery and internalization of substances to cells. We have utilized asialoglycoprotein receptors on hepatocytes to target DNA specifically to these cells. Studies initially began with marker genes in cell culture studies. More recently, normal genes in the form of targetable protein-DNA complexes have been introduced into animals possessing inherited metabolic disorders. Partial, transient corrections of these diseases have been achieved by intravenous injection of the complexed genes.
引用
收藏
页码：159 / 167
页数：9
相关论文
共 50 条
  • [31] CELL TRANSPLANTATION IN LIVER-DIRECTED GENE-THERAPY - COMMENTARY
    VACANTI, JP
    CELL TRANSPLANTATION, 1993, 2 (05) : 409 - 410
  • [32] Liver-directed gene targeting as a potential therapy for Fabry disease
    Saxena, H.
    Biasizzo, J.
    Domenis, R.
    Zentilin, L.
    Dardis, A.
    Muro, A. F.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A170 - A170
  • [33] Liver-Directed Gene Targeting as a Potential Therapy for Fabry Disease
    Saxena, Himanshi
    Biasizzo, Jessica
    Domenis, Rossana
    Zentilin, Lorena
    Dardis, Andrea
    Muro, Andres F.
    MOLECULAR THERAPY, 2024, 32 (04) : 733 - 733
  • [34] Therapeutic Thresholds for Liver-Directed Gene Therapy of Phenylketonuria (PKU)
    Hamman, Kelly
    Harding, Cary O.
    MOLECULAR THERAPY, 2009, 17 : S68 - S68
  • [35] Liver-directed gene targeting as a potential therapy for Fabry disease
    Saxena, H.
    Biasizzo, J.
    Domenis, R.
    Zentilin, L.
    Dardis, A.
    Muro, A. F.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A241 - A241
  • [36] Liver-directed gene transfer in non-human primates
    Sullivan, DE
    Dash, S
    Du, H
    Hiramatsu, N
    Aydin, F
    Kolls, J
    Blanchard, J
    Baskin, G
    Gerber, MA
    HUMAN GENE THERAPY, 1997, 8 (10) : 1195 - 1206
  • [37] Liver-directed gene therapy for factor-VIII deficiency
    vanderEb, AJ
    Hoeben, RC
    Fallaux, F
    vanOrmondt, H
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 1996, 21 (01) : 78 - 80
  • [38] Efficacy Evaluation of Liver-Directed Gene Theraphy in Fabry Mice
    Kia, Azadeh
    McIntosh, Jenny
    Rosales, Cecilia
    Hosseini, Paniz
    Sheridan, Rose
    Spiewak, Justyna
    Mills, Kevin
    Corbau, Romuald
    Nathwani, Amit C.
    BLOOD, 2018, 132
  • [39] Recent advances in liver-directed gene therapy for dyslipidemia.
    Oka K.
    Chan L.
    Current Atherosclerosis Reports, 2002, 4 (3) : 199 - 207
  • [40] Liver-directed gene therapy corrects Fabry disease in mice
    Jeyakumar, Jey
    Kia, Azadeh
    McIntosh, Jenny
    Verhoef, Daniel
    Kalcheva, Petya
    Hosseini, Paniz
    Sheridan, Rose
    Corbau, Romuald
    Nathwani, Amit
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S80 - S80
12345